RP Bio lnc (XKRX:314140) EV-to-EBIT : 12.82 (As of May. 13, 2024)

RP Bio lnc EV-to-EBIT Chart

RP Bio lnc Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial					17.88	30.82	28.70	15.68	12.48

Competitive Comparison of RP Bio lnc's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, RP Bio lnc's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RP Bio lnc's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RP Bio lnc's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where RP Bio lnc's EV-to-EBIT falls into.

RP Bio lnc EV-to-EBIT Calculation

RP Bio lnc's EV-to-EBIT for today is calculated as:

RP Bio lnc's current Enterprise Value is ₩95,553 Mil.
RP Bio lnc's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩7,453 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RP Bio lnc  (XKRX:314140) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

RP Bio lnc's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

RP Bio lnc's Enterprise Value for the quarter that ended in Dec. 2023 was ₩93,045 Mil.
RP Bio lnc's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩7,453 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RP Bio lnc EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of RP Bio lnc's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

RP Bio lnc (XKRX:314140) Business Description